Psyence Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBM and other ETFs, options, and stocks.

About PBM

Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. 

CEO
Jody Aufrichtig
CEOJody Aufrichtig
Employees
12
Employees12
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
2021
Founded2021
Employees
12
Employees12

PBM Key Statistics

Market cap
2.98M
Market cap2.98M
Price-Earnings ratio
0.89
Price-Earnings ratio0.89
Dividend yield
Dividend yield
Average volume
1.82M
Average volume1.82M
High today
$1.63
High today$1.63
Low today
$1.46
Low today$1.46
Open price
$1.54
Open price$1.54
Volume
338.65K
Volume338.65K
52 Week high
$62.72
52 Week high$62.72
52 Week low
$1.41
52 Week low$1.41

Stock Snapshot

Psyence Biomedical(PBM) stock is priced at $1.51, giving the company a market capitalization of 2.98M. It carries a P/E multiple of 0.89.

As of 2025-12-13, Psyence Biomedical(PBM) stock has fluctuated between $1.46 and $1.63. The current price stands at $1.51, placing the stock +3.4% above today's low and -7.4% off the high.

Psyence Biomedical(PBM) shares are trading with a volume of 338.65K, against a daily average of 1.82M.

During the past year, Psyence Biomedical(PBM) stock moved between $1.41 at its lowest and $62.72 at its peak.

During the past year, Psyence Biomedical(PBM) stock moved between $1.41 at its lowest and $62.72 at its peak.

PBM News

TipRanks 4d
Psyence Biomedical CEO says 2025 was a ‘turning point’ for company

Psyence Biomedical (PBM) released a year-end Letter from CEO Jody Aufrichtig, summarizing the Company’s 2025 achievements and outlining its strategic vision for...

People also own

Based on the portfolios of people who own PBM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.